Risk Factors for Multidrug Resistance in Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Nomogram
Yaning Gao,Liang Chen,Zhengjun Wen,Huiying Jiang,Jing Feng
DOI: https://doi.org/10.2147/idr.s479374
2024-11-04
Infection and Drug Resistance
Abstract:Yaning Gao, Liang Chen, Zhengjun Wen, Huiying Jiang, Jing Feng Respiratory and Critical Care Medicine Department, Beijing Jingmei Group General Hospital, Beijing, People's Republic of China Correspondence: Liang Chen, Email Purpose: Our aim was to determine the risk factors for multidrug resistance in patients with carbapenem-resistant Klebsiella pneumoniae (CRKP). Methods: The information of 196 patients with Klebsiella pneumoniae infection was collected. The patients were subsequently assigned to the carbapenem-resistant, multidrug-resistant, and non-multidrug-resistant groups. The risk factors for multidrug resistance in CRKP patients were assessed via least absolute shrinkage and selection operator and logistic regression analyses. Moreover, a nomogram was constructed dependent on the identified risk factors, and calibration and decision curves were plotted to detect its accuracy. Results: Length of stay (LOS) [odds ratio (OR) and 95% confidence interval (CI): 4.558 (1.157– 17.961), P = 0.030], intensive care unit (ICU) stay within 30 days [OR and 95% CI: 12.643 (3.780– 42.293), P < 0.001], Glasgow Coma Scale (GCS) score [OR and 95% CI: 13.569 (2.738– 67.236), P = 0.001], fungal infection [OR and 95% CI: 6.398 (1.969– 20.785), P = 0.002], and cardiovascular disease (CVD) [OR and 95% CI: 3.871 (1.293– 11.592), P = 0.016] were identified as risk factors for multidrug resistance in CRKP patients. The concordance index (C-index) of the constructed nomogram was 0.950 (95% CI: 0.945– 0.955). Moreover, decision curve analysis elucidated the nomogram utilization across a wide range of probability thresholds, ranging from 1% to 100%. Finally, internal validation using random data validated the robustness of the predictive model, yielding a C-index of 0.937. Conclusion: The LOS, ICU stay within 30 days, GCS score, fungal infection, and CVD were recognized as risk factors for multidrug resistance in CRKP patients. The constructed nomogram could accurately predict multidrug-resistant CRKP infections in patients. Plain Language Summary: The LOS, ICU stay within 30 days, GCS, fungal infection, and CVD were identified as risk factors for multidrug resistance in CRKP patients.The nomogram constructed in this study had high predictive accuracy.This study provides a reference for the formulation of personalized prevention and therapy strategies. Keywords: Klebsiella pneumoniae , multidrug resistance, carbapenem, prediction model, risk factors Klebsiella pneumoniae (KP) is a gram-negative pathogenic bacterium commonly present in clinical specimens. 1–3 It is the most important conditional pathogenic bacteria in immunocompromised patients and causes respiratory tract infections. 4–6 Besides causing respiratory tract infections, KP can also cause infections in multiple systems, such as the digestive tract, blood, and urinary system. 7–9 During the early stages of KP infection, patients are typically asymptomatic, leading to an underestimation of disease severity in clinical practice. 10 Moreover, treatment outcomes for KP are frequently sub-optimal, contributing to the high mortality rates of patients. 11 Recently, with the extensive use and irrational administration of antibiotics, the detection rate of multidrug resistance among CRKP strains has been steadily rising. 12–15 Elevating resistance to colistin in KP uropathogens due to chromosomal mutations and plasmid-mediated mcr genes leads to chronic severe and recurrent UTI in clinical settings. 16 Of 240 carbapenem- and colistin-resistant KP isolates in Thailand, 220 isolates (91.7%) were resistant to tigecycline, and most of the isolates were resistant to fosfomycin (70.4%). 17 In 2016, the European Resistance Surveillance Network reported resistance rates of KP to carbapenem drugs ranging between 30.0–66.9% across three countries. 18 Similarly, the 2018 China Bacterial Resistance Monitoring Network data revealed that the KP resistance rates to third-generation cephalosporins and carbapenem drugs in various provinces and cities ranged between 12.3–55.8% and 0.7%–32.5%, respectively. 19 From 2015 to 2019, the KP resistance rates to imipenem and meropenem detected in the departments of critical care and respiratory medicine in Chongqing fuling center hospital were 17.02%, 14.90%, and 30.77%, respectively. 20 Therefore, early identification of risk factors for multidrug resistance holds considerable implications for disease prevention and disease progression, as well as for reducing the burden on patients and society. As a mathematical model featuring an intuitive visual presentation, a nomogram considers t -Abstract Truncated-
pharmacology & pharmacy,infectious diseases